Press Releases July 31, 2026 08:30 AM

Nasdaq Resumes Trading in Inno Holdings Inc.

Nasdaq Resumes Trading of Inno Holdings After Nearly Two Months Halt

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
INHD

The Nasdaq Stock Market has resumed trading of Inno Holdings Inc. (INHD) at noon on July 31, 2026, following a trading halt that began on June 8, 2026. The reason for the halt was not disclosed in the announcement. Investors can now trade the company’s shares again on Nasdaq.

Nasdaq Resumes Trading in Inno Holdings Inc.
INHD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Trading of Inno Holdings Inc. was halted on June 8, 2026, and resumed on July 31, 2026.
  • The halt lasted approximately seven weeks, which may have been due to company-specific issues or regulatory matters.
  • The company’s shares are listed and traded on the Nasdaq stock exchange, indicating it is a U.S.-listed company.

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in Inno Holdings Inc. (Nasdaq: INHD) at 12:00 p.m. Eastern Time on July 31, 2026. Trading in the company’s ordinary shares was halted on June 8, 2026 at 17:18:58 Eastern Time.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

Nasdaq Contact:

Nasdaq MarketWatch
[email protected]

NDAQO


Risks

  • The cause of the prior trading halt was not specified, indicating potential underlying issues that could affect investor confidence.
  • There may still be uncertainty about the company's financial or operational status impacting market performance post-resumption.
  • Any unresolved regulatory or compliance matters could pose ongoing risks to stock value.

More from Press Releases

Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026 Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026 Nov 12, 2026 UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights Nov 4, 2026 BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Nov 4, 2026 Jasper Therapeutics Announces 1-for-30 Reverse Stock Split Nov 4, 2026